| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.14M | 22.61M | 20.45M | 19.10M | 18.05M | 21.01M |
| Gross Profit | 19.46M | 18.92M | 17.04M | 15.79M | 14.86M | 13.10M |
| EBITDA | 8.70M | 8.95M | 7.61M | 7.11M | 5.38M | 5.41M |
| Net Income | 7.13M | 6.98M | 5.96M | 5.59M | 4.00M | 4.12M |
Balance Sheet | ||||||
| Total Assets | 55.61M | 55.33M | 51.60M | 50.58M | 49.32M | 55.05M |
| Cash, Cash Equivalents and Short-Term Investments | 28.79M | 28.57M | 25.15M | 23.99M | 21.46M | 24.07M |
| Total Debt | 457.30K | 509.97K | 545.10K | 747.11K | 2.97M | 6.70M |
| Total Liabilities | 5.44M | 5.81M | 4.74M | 4.70M | 6.42M | 9.91M |
| Stockholders Equity | 50.17M | 49.52M | 46.85M | 45.88M | 42.90M | 45.14M |
Cash Flow | ||||||
| Free Cash Flow | 8.06M | 8.40M | 6.89M | 7.96M | 6.05M | 5.08M |
| Operating Cash Flow | 8.09M | 8.42M | 6.96M | 8.86M | 6.10M | 5.40M |
| Investing Cash Flow | -54.28K | 169.00 | -100.71K | -903.19K | 1.32M | -318.87K |
| Financing Cash Flow | -5.03M | -5.01M | -5.70M | -5.43M | -10.03M | -1.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $211.96M | 32.14 | 14.60% | 0.57% | 11.05% | 18.55% | |
66 Neutral | $236.03M | 1.45 | ― | 14.78% | -19.17% | 308.81% | |
62 Neutral | $346.24M | -5.12 | -25.48% | ― | -24.30% | -181.62% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | $338.00M | -10.77 | -20.20% | ― | -6.23% | 28.57% | |
48 Neutral | $620.10M | -9.09 | -28.65% | ― | 16.40% | 22.80% | |
48 Neutral | $264.80M | -42.44 | -4.88% | ― | 0.25% | 92.10% |
On December 19, 2025, ReposiTrak, Inc. declared a quarterly cash dividend of $0.02 per share, equivalent to $0.08 per share on an annualized basis, on its common stock. The dividend will be paid on or about February 13, 2026, to shareholders of record as of December 31, 2025, with subsequent quarterly dividends expected to be paid within 45 days of each fiscal quarter end, signaling an ongoing capital return program that may underscore management’s confidence in the company’s cash generation and financial stability for investors.
The most recent analyst rating on (TRAK) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.
On December 4, 2025, ReposiTrak announced that its Board of Directors approved a new 10B5-1 share repurchase program, allowing the company to buy back up to $2 million of its common stock. This initiative is part of a larger $21 million repurchase program, with $7.6 million still available for repurchase. The 10B5-1 plan is a strategic move to optimize capital allocation, facilitating the repurchase and retirement of common shares, alongside other initiatives like redeeming preferred shares and paying dividends.
The most recent analyst rating on (TRAK) stock is a Buy with a $14.50 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.
On November 19, 2025, ReposiTrak, Inc. held its Annual Meeting of Stockholders where several key proposals were voted on. The election of directors resulted in the re-election of all nominees, and stockholders approved the executive compensation on a non-binding advisory basis. Additionally, it was decided that the advisory vote on executive compensation will occur every three years, and Haynie & Company was ratified as the independent auditor for the fiscal year ending June 30, 2026.
The most recent analyst rating on (TRAK) stock is a Buy with a $16.50 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.
ReposiTrak reported a 10% increase in revenue to $6.0 million for the first fiscal quarter ending September 30, 2025, with a 13% rise in earnings per share. The company maintained a strong financial position with $29 million in cash and no debt, while also increasing its quarterly dividend by 10%. The company’s focus on automation and operational efficiency is expected to support smaller market participants and enhance profitability, strengthening its competitive position in the traceability and compliance market.
The most recent analyst rating on (TRAK) stock is a Buy with a $16.50 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.